Literature DB >> 17850767

Behavioral modulation of neuronal calcium/calmodulin-dependent protein kinase II activity: differential effects on nicotine-induced spinal and supraspinal antinociception in mice.

M Imad Damaj1.   

Abstract

Recent studies have implicated the involvement of Ca(2+)-dependent mechanisms, in particular calcium/calmodulin-dependent protein kinase II (CaM kinase II) in nicotine-induced antinociception using the tail-flick test. The spinal cord was suggested as a possible site of this involvement. The present study was undertaken to investigate the hypothesis that similar mechanisms exist for nicotine-induced antinociception in the hot-plate test, a response thought to be centrally mediated. In order to assess these mechanisms, i.c.v. administered CaM kinase II inhibitors were evaluated for their effects on antinociception produced by either i.c.v. or s.c. administration of nicotine in both tests. In addition, nicotine's analgesic effects were tested in mice lacking half of their CaM kinase II (CaM kinase II heterozygous) and compare it to their wild-type counterparts. Our results showed that although structurally unrelated CaM kinase II inhibitors blocked nicotine's effects in the tail-flick test in a dose-related manner, they failed to block the hot-plate responses. In addition, the antinociceptive effects of systemic nicotine in the tail-flick but not the hot-plate test were significantly reduced in CaM kinase II heterozygous mice. These observations indicate that in contrast to the tail-flick response, the mechanism of nicotine-induced antinociception in the hot-plate test is not mediated primarily via CaM kinase II-dependent mechanisms at the supraspinal level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850767      PMCID: PMC2683468          DOI: 10.1016/j.bcp.2007.07.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

2.  The spinal cord as a major site for the antinociceptive action of nicotine in the rat.

Authors:  M D Aceto; R S Bagley; W L Dewey; T C Fu; B R Martin
Journal:  Neuropharmacology       Date:  1986-09       Impact factor: 5.250

3.  Antin ociceptive activity of nicotine.

Authors:  D V Phan; M Dóda; A Bite; L György
Journal:  Acta Physiol Acad Sci Hung       Date:  1973

4.  Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.

Authors:  M I Damaj; C Fonck; M J Marks; P Deshpande; C Labarca; H A Lester; A C Collins; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  2007-03-19       Impact factor: 4.030

5.  The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice.

Authors:  M I Damaj
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

6.  Antinociceptive effects of the stereoisomers of nicotine given intrathecally in spinal rats.

Authors:  M K Christensen; D F Smith
Journal:  J Neural Transm Gen Sect       Date:  1990

7.  Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice.

Authors:  N W Pedigo; W L Dewey; L S Harris
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

8.  Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and the nucleus raphe magnus.

Authors:  E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

9.  Adrenergic, serotonergic and cholinergic components of nicotinic antinociception in rats.

Authors:  E T Iwamoto; L Marion
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

10.  Multiple spinal mediators in parenteral nicotine-induced antinociception.

Authors:  D T Rogers; E T Iwamoto
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

View more
  9 in total

1.  Neuronal calcium/calmodulin-dependent protein kinase II mediates nicotine reward in the conditioned place preference test in mice.

Authors:  Kia J Jackson; Pretal P Muldoon; Carrie Walters; Mohamad Imad Damaj
Journal:  Behav Pharmacol       Date:  2016-02       Impact factor: 2.293

2.  Smoking status and pain level among head and neck cancer patients.

Authors:  Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

3.  Beta2-containing nicotinic acetylcholine receptors mediate calcium/calmodulin-dependent protein kinase-II and synapsin I protein levels in the nucleus accumbens after nicotine withdrawal in mice.

Authors:  Kia J Jackson; M Imad Damaj
Journal:  Eur J Pharmacol       Date:  2013-01-10       Impact factor: 4.432

4.  Calcium/calmodulin-dependent protein kinase IV mediates acute nicotine-induced antinociception in acute thermal pain tests.

Authors:  Kia J Jackson; Mohamad I Damaj
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

Review 5.  Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction.

Authors:  Angela M Lee; Marina R Picciotto
Journal:  Adv Pharmacol       Date:  2020-10-06

6.  Characterization of the Antinociceptive Mechanisms of Khat Extract (Catha edulis) in Mice.

Authors:  Elham A Afify; Huda M Alkreathy; Ahmed S Ali; Hassan A Alfaifi; Lateef M Khan
Journal:  Front Neurol       Date:  2017-03-02       Impact factor: 4.003

7.  Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems.

Authors:  Elham A Afify; Najlaa M Andijani
Journal:  Front Pharmacol       Date:  2017-11-10       Impact factor: 5.810

8.  Scabronine G Methyl Ester Improves Memory-Related Behavior and Enhances Hippocampal Cell Proliferation and Long-Term Potentiation via the BDNF-CREB Pathway in Olfactory Bulbectomized Mice.

Authors:  Osamu Nakagawasai; Jia-Rong Lin; Takayo Odaira; Kohei Takahashi; Wataru Nemoto; Shigeki Moriguchi; Yasushi Yabuki; Yu Kobayakawa; Kohji Fukunaga; Masahisa Nakada; Koichi Tan-No
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

9.  Exploring the nicotinic acetylcholine receptor-associated proteome with iTRAQ and transgenic mice.

Authors:  Tristan D McClure-Begley; Kathy L Stone; Michael J Marks; Sharon R Grady; Christopher M Colangelo; Jon M Lindstrom; Marina R Picciotto
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-07-25       Impact factor: 7.691

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.